Drug information for MYCIFRADIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION; ORAL EQ 87.5MG BASE/5ML Discontinued   NEOMYCIN SULFATE Neomycin PHARMACIA AND UPJOHN 50285
TABLET; ORAL EQ 350MG BASE Discontinued   NEOMYCIN SULFATE Neomycin PHARMACIA AND UPJOHN 60520

Drug Adverse Effects information for MYCIFRADIN

Role code Indications Reaction # Reports
C LAPAROSCOPIC SURGERY ANAEMIA 1
C LAPAROSCOPIC SURGERY ANXIETY 1
C LAPAROSCOPIC SURGERY DEHYDRATION 1
C LAPAROSCOPIC SURGERY HYPOVOLAEMIA 1
C LAPAROSCOPIC SURGERY INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C LAPAROSCOPIC SURGERY POST PROCEDURAL COMPLICATION 1
C LAPAROSCOPIC SURGERY RENAL FAILURE ACUTE 1
C LAPAROSCOPIC SURGERY RENAL TUBULAR NECROSIS 1
Ads by Google